2024 Fall Conference | C26 - Neurology Update 8: Neuro-oncology; Neuro-ophthalmology

Date Sunday 10/27/24

Time 09:30 AM - 11:00 AM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Vijay K. Ramanan, MD, PhD, Casey S. Albin, MD

Topic(s) General Neurology, Neuro-oncology, Neuro-ophthalmology/Neuro-otology

Learning Objectives Neuro-oncology: After attending this discussion, participants will be able to: describe standard of care for primary tumors and new options for these neoplasms; use knowledge of emerging targeted therapies for brain metastasis to refer patients for timely clinical interventions; develop a systematic approach to undiagnosed brain masses with particular attention to possible CNS lymphoma; appreciate the problem of stroke in cancer patients and employ evidence-based treatment strategies; diagnose and manage the neurological complications of immune checkpoint inhibitor and CAR T cell therapies.
Neuro-ophthalmology: During this session participants will identify important details from videotaped patient histories and examinations to make uncommon but important neuro-ophthalmological diagnoses; gain knowledge about the historical description and current neuroscientific understanding of these neuro-ophthalmologic conditions; appreciate how accurate diagnosis guides specific evidence-based therapeutic interventions.

CME Available 1.50 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Teaching Styles Didactic

Program Materials

Event Timeline
09:30 AM - 10:15 AM PDT	Speaker	Neuro-oncology Amy A. Pruitt, MD, FAAN
10:15 AM - 11:00 AM PDT	Speaker	Neuro-ophthalmology Sashank Prasad, MD

Faculty Disclosures
Vijay K. Ramanan, MD, PhD	The institution of Dr. Ramanan has received research support from the National Institutes of Health. The institution of Dr. Ramanan has received research support from the Mangurian Foundation for Lewy Body Disease Research. The institution of Dr. Ramanan has received research support from as part of clinical trials sponsored by the Alzheimer's Association, Eisai, the Alzheimer's Treatment and Research Institute at USC, and Transposon Therapeutics, Inc.. The institution of Dr. Ramanan has received research support from Medscape. Dr. Ramanan has received personal compensation in the range of $500-$4,999 for serving as a Conference Speaker/Organizer (Honoraria) with AANI.
Casey S. Albin, MD	Dr. Albin has received personal compensation in the range of $0-$499 for serving as a Consultant for Azurity Pharmaceutical. Dr. Albin has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Continuum: Life Long Learning in Neurology. Dr. Albin has received research support from American Academy of Neurology. Dr. Albin has received publishing royalties from a publication relating to health care. Dr. Albin has received personal compensation in the range of $500-$4,999 for serving as a Instructor with Resuscitation Leadership Academy.
Amy A. Pruitt, MD, FAAN	Dr. Pruitt has nothing to disclose.
Sashank Prasad, MD	Dr. Prasad has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Medicolegal firms. Dr. Prasad has received publishing royalties from a publication relating to health care.